- Stocks
- Pharma & Healthcare
- Panchsheel Org
Panchsheel Org share price
NSE: PANCHSHEELPharma & HealthcareDrug Manufacturers - Specialty & Generic
Panchsheel Org at a glance
With a market capitalisation of ₹159 Cr, it ranks 2411th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
Its return on equity was 10.3% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹31 Cr (+9.5% year on year) and net profit ₹2 Cr (−46.4%), on a standalone basis. Promoters held 56.12% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹159 CrRank 2411 on NSE
- Price to book
- 1.33×FY25
- EPS (TTM)
- ₹8.22to Q4 FY26
- ROE
- 10.3%FY25
- ROCE
- 13.3%FY25
- Debt to equity
- 0.04FY25
- Net profit margin
- 12.9%FY25
- Book value / share
- ₹101.63FY25
- Dividend payout
- 30.6%FY25
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Panchsheel Org quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹26 Cr | ₹27 Cr | ₹26 Cr | ₹28 Cr | ₹24 Cr | ₹25 Cr | ₹27 Cr | ₹31 Cr |
| Revenue YoY | +5.8% | +14.6% | +2.5% | −9.3% | −9.6% | −6.8% | +1.9% | +9.5% |
| Net profit | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr |
| Net profit YoY | +1.2% | +2.7% | −13.8% | +14.0% | −16.9% | −31.1% | +0.3% | −46.4% |
| Net margin | 13.2% | 13.9% | 14.0% | 11.2% | 12.1% | 10.3% | 13.8% | 5.5% |
| EPS | ₹2.60 | ₹2.88 | ₹2.79 | ₹2.41 | ₹2.16 | ₹1.98 | ₹2.79 | ₹1.29 |
Panchsheel Org financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹51 Cr | ₹49 Cr | ₹69 Cr | ₹103 Cr | ₹105 Cr | ₹107 Cr |
| Operating profit | ₹7 Cr | ₹7 Cr | ₹11 Cr | ₹19 Cr | ₹19 Cr | ₹18 Cr |
| Net profit | ₹5 Cr | ₹5 Cr | ₹8 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
| EPS (₹) | ₹10.55 | ₹9.98 | ₹8.33 | ₹12.78 | ₹11.88 | ₹10.47 |
| Cash from operations | ₹5 Cr | ₹5 Cr | −₹2 Cr | ₹0 Cr | ₹10 Cr | ₹4 Cr |
| Total debt | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹35 Cr | ₹40 Cr | ₹47 Cr | ₹96 Cr | ₹125 Cr | ₹134 Cr |
Panchsheel Org shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 56.12% | 56.12% | 56.12% | 56.12% | 56.12% | 56.12% |
| Non-institutions | 42.89% | 43.88% | 43.88% | 43.88% | 43.88% | 43.88% |
Panchsheel Org vs peers
The listed Pharma & Healthcare companies nearest to Panchsheel Org by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| TAKETake Solutions | ₹11.96 | −5.23% | −25.9% | ₹177 Cr | 41.2 | — |
| BALPHARMABal Pharma | ₹109.58 | −2.16% | +28.9% | ₹174 Cr | 27.7 | — |
| MADHAVBAUGVaidya Sane Ayu | ₹161.10 | −4.11% | −43.1% | ₹169 Cr | — | — |
| NATCAPSUQNatural Capsules | ₹162.00 | +1.25% | −32.2% | ₹169 Cr | — | — |
| PANCHSHEELPanchsheel Org | — | — | — | ₹159 Cr | — | — |
| AUROLABAuro Labs | — | — | — | ₹156 Cr | — | — |
| KIMIABLKimia Bio | — | — | — | ₹152 Cr | — | — |
Ask anything about Panchsheel Org
Pivot answers on the live chart with evidence you can check, and tests strategies against PANCHSHEEL's own history. Try: “Why has PANCHSHEEL moved over the last three months?” · “Backtest a 50-day moving-average crossover on PANCHSHEEL over five years” · “Compare PANCHSHEEL with TAKE on margins and valuation”
Frequently asked questions about Panchsheel Org
What is the market cap of Panchsheel Org?
Panchsheel Org's market capitalisation is ₹159 Cr (₹159 Cr) at the 19 Oct 2026 close, ranking 2411th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Panchsheel Org?
Return on equity was 10.3% in FY25 and return on capital employed was 13.3% in FY25 (standalone figures).
Is Panchsheel Org a debt-free company?
Panchsheel Org is close to debt-free: its debt-to-equity ratio was 0.04 in FY25.
What were Panchsheel Org's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Panchsheel Org reported revenue of ₹31 Cr, +9.5% year on year, and net profit of ₹2 Cr, −46.4% year on year.
What is the shareholding pattern of Panchsheel Org?
As of 30 Jun 2026: promoters 56.12%, non-institutions 43.88%.
Who are Panchsheel Org's competitors?
The listed Pharma & Healthcare companies closest to Panchsheel Org by market cap are Take Solutions, Bal Pharma, Vaidya Sane Ayu, Natural Capsules, Auro Labs and Kimia Bio.
Is Panchsheel Org a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Panchsheel Org's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on PANCHSHEEL against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 19 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with P · all NSE stocks · this page as text